Joubert syndrome and related disorders
diseaseOn this page
Also known as JSRD
Summary
Joubert syndrome and related disorders (MONDO:0015369) is a disease with 27 cohort genes. The dominant Reactome pathway is Anchoring of the basal body to the plasma membrane (13 cohort genes).
At a glance
- Prevalence: >1 / 1000 (North America) [Orphanet-validated]
- Cohort genes: 27
- ClinVar variants: 253
Clinical features
Epidemiology
Prevalence records
4 prevalence record(s), Orphanet:
| Type | Class | Value | Geography | Validation |
|---|---|---|---|---|
| Prevalence at birth | 1-9 / 100 000 | 1.1 | Worldwide | Validated |
| Point prevalence | >1 / 1000 | 666.67 | North America | Validated |
| Prevalence at birth | 1-9 / 100 000 | 1 | United States | Validated |
| Prevalence at birth | 1-9 / 100 000 | 1 | Netherlands | Validated |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | Joubert syndrome and related disorders |
| Mondo ID | MONDO:0015369 |
| Orphanet | 140874 |
| UMLS | C5679612 |
| MedGen | 1826007 |
| GARD | 0019931 |
| Is cancer (heuristic) | no |
Also known as: Joubert syndrome and related disorders · JSRD
Data availability: 253 ClinVar variants.
Disease family
An umbrella term covering 4 Mondo subtypes.
Classification path: disease › human disease › disease by etiologic mechanism › disease of genetic or genomic mechanism › hereditary disease › autosomal genetic disease › autosomal recessive disease › autosomal recessive cerebellar ataxia › autosomal recessive congenital cerebellar ataxia › Joubert syndrome and related disorders
Related subtypes (6): autosomal recessive spinocerebellar ataxia 2, cerebellar ataxia, intellectual disability, and dysequilibrium, Cayman type cerebellar ataxia, autosomal recessive spinocerebellar ataxia 17, CAMOS syndrome, congenital cerebellar ataxia due to RNU12 mutation
Subtypes (4): Joubert syndrome with oculorenal defect, Joubert syndrome with ocular defect, Joubert syndrome with Jeune asphyxiating thoracic dystrophy, COACH syndrome
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
ClinVar germline variants
253 retrieved; paginated sample, class counts are floors:
82 pathogenic/likely pathogenic, 78 likely pathogenic, 63 pathogenic, 25 conflicting classifications of pathogenicity, 5 uncertain significance
| ClinVar | Variant (HGVS) | Gene | Classification | Review |
|---|---|---|---|---|
| 1075243 | NM_001134831.2(AHI1):c.1983del (p.Trp662fs) | AHI1 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 2168890 | NM_001134831.2(AHI1):c.101del (p.Lys34fs) | AHI1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 217523 | NM_001134831.2(AHI1):c.1267C>T (p.Gln423Ter) | AHI1 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 217524 | NM_001134831.2(AHI1):c.2495T>G (p.Leu832Ter) | AHI1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 217534 | NM_001134831.2(AHI1):c.1516C>T (p.Arg506Ter) | AHI1 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 217536 | NM_001134831.2(AHI1):c.910dup (p.Thr304fs) | AHI1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 217538 | NM_001134831.2(AHI1):c.662C>G (p.Ser221Ter) | AHI1 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 217542 | NM_001134831.2(AHI1):c.736A>T (p.Lys246Ter) | AHI1 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 217543 | NM_001134831.2(AHI1):c.1260G>A (p.Trp420Ter) | AHI1 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 2907129 | NM_001134831.2(AHI1):c.195_202del (p.Asp65fs) | AHI1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 3366410 | NC_000006.11:g.(135732683_135748304)_(135752453_135754164)del | AHI1 | Pathogenic | criteria provided, single submitter |
| 3366415 | NC_000006.11:g.(135732683_135748304)_(135751139_135752345)del | AHI1 | Pathogenic | criteria provided, single submitter |
| 3769079 | NM_001134831.2(AHI1):c.630_631del (p.Lys211fs) | AHI1 | Pathogenic | criteria provided, single submitter |
| 568060 | NM_001134831.2(AHI1):c.2105C>T (p.Thr702Met) | AHI1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 624266 | NM_001134831.2(AHI1):c.3032C>G (p.Ser1011Ter) | AHI1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 661866 | NM_001134831.2(AHI1):c.2492+1G>A | AHI1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 936055 | NM_001134831.2(AHI1):c.484C>T (p.Gln162Ter) | AHI1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 1993 | NM_001174150.2(ARL13B):c.598C>T (p.Arg200Cys) | ARL13B | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 2203408 | NM_001174150.2(ARL13B):c.223G>A (p.Gly75Arg) | ARL13B | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 266096 | NM_001174150.2(ARL13B):c.599G>A (p.Arg200His) | ARL13B | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 631931 | NM_001174150.2(ARL13B):c.830dup (p.Asn277fs) | ARL13B | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 217556 | NM_030578.4(B9D2):c.463G>A (p.Gly155Ser) | B9D2 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 217558 | NM_030578.4(B9D2):c.220C>T (p.Pro74Ser) | B9D2 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 30931 | NM_030578.4(B9D2):c.301A>C (p.Ser101Arg) | B9D2 | Pathogenic | criteria provided, single submitter |
| 1453471 | NM_001378615.1(CC2D2A):c.2999_3000inv (p.Glu1000Val) | CC2D2A | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 217607 | NM_001378615.1(CC2D2A):c.4667A>T (p.Asp1556Val) | CC2D2A | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 2203534 | NM_001378615.1(CC2D2A):c.2581G>A (p.Asp861Asn) | CC2D2A | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 1343654 | NM_014704.4(CEP104):c.1051_1054del (p.Thr351fs) | CEP104 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 1700581 | NM_014704.4(CEP104):c.643C>T (p.Arg215Ter) | CEP104 | Pathogenic | criteria provided, single submitter |
| 2691290 | NM_014704.4(CEP104):c.1232del (p.Gly411fs) | CEP104 | Pathogenic | criteria provided, single submitter |
Genes & proteins
Mendelian disease overlap and somatic drivers
GenCC: 0 · Orphanet: 72 · OMIM-shared: 0 · Dual-evidence (GWAS+Mendelian): 0
Orphanet rare-disease linkage (cohort genes)
| Gene | Orphanet ID | Rare disease |
|---|---|---|
| TMEM237 | Orphanet:220497 | Joubert syndrome with renal defect |
| TMEM237 | Orphanet:2318 | Joubert syndrome with oculorenal defect |
| TMEM237 | Orphanet:475 | Isolated Joubert syndrome |
| TMEM237 | Orphanet:564 | Meckel syndrome |
| PMPCA | Orphanet:1170 | Autosomal recessive cerebelloparenchymal disorder type 3 |
| KIF14 | Orphanet:2512 | Autosomal recessive primary microcephaly |
| KIF14 | Orphanet:439897 | Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome |
| KIAA0586 | Orphanet:397715 | Joubert syndrome with Jeune asphyxiating thoracic dystrophy |
| KIAA0586 | Orphanet:475 | Isolated Joubert syndrome |
| INPP5E | Orphanet:1454 | Joubert syndrome with hepatic defect |
| INPP5E | Orphanet:220493 | Joubert syndrome with ocular defect |
| INPP5E | Orphanet:475 | Isolated Joubert syndrome |
| INPP5E | Orphanet:75858 | MORM syndrome |
| AHI1 | Orphanet:220493 | Joubert syndrome with ocular defect |
| AHI1 | Orphanet:475 | Isolated Joubert syndrome |
| AHI1 | Orphanet:791 | Retinitis pigmentosa |
| B9D1 | Orphanet:475 | Isolated Joubert syndrome |
| B9D1 | Orphanet:564 | Meckel syndrome |
| TCTN3 | Orphanet:2753 | Orofaciodigital syndrome type 4 |
| TCTN3 | Orphanet:2754 | Orofaciodigital syndrome type 6 |
| TCTN3 | Orphanet:475 | Isolated Joubert syndrome |
| TCTN3 | Orphanet:564 | Meckel syndrome |
| CEP104 | Orphanet:475 | Isolated Joubert syndrome |
| CEP104 | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| TMEM216 | Orphanet:2318 | Joubert syndrome with oculorenal defect |
| TMEM216 | Orphanet:2754 | Orofaciodigital syndrome type 6 |
| TMEM216 | Orphanet:564 | Meckel syndrome |
| TMEM216 | Orphanet:791 | Retinitis pigmentosa |
| ARL13B | Orphanet:475 | Isolated Joubert syndrome |
| TCTN2 | Orphanet:475 | Isolated Joubert syndrome |
| TCTN2 | Orphanet:564 | Meckel syndrome |
| CPLANE1 | Orphanet:2754 | Orofaciodigital syndrome type 6 |
| CPLANE1 | Orphanet:475 | Isolated Joubert syndrome |
| CPLANE1 | Orphanet:65684 | Monomelic amyotrophy |
| TCTN1 | Orphanet:475 | Isolated Joubert syndrome |
| TCTN1 | Orphanet:564 | Meckel syndrome |
| TMEM138 | Orphanet:2318 | Joubert syndrome with oculorenal defect |
| TMEM67 | Orphanet:140976 | RHYNS syndrome |
| TMEM67 | Orphanet:1454 | Joubert syndrome with hepatic defect |
| TMEM67 | Orphanet:475 | Isolated Joubert syndrome |
| TMEM67 | Orphanet:564 | Meckel syndrome |
| TMEM67 | Orphanet:84081 | Senior-Boichis syndrome |
| B9D2 | Orphanet:475 | Isolated Joubert syndrome |
| B9D2 | Orphanet:564 | Meckel syndrome |
| CEP290 | Orphanet:110 | Bardet-Biedl syndrome |
| CEP290 | Orphanet:2318 | Joubert syndrome with oculorenal defect |
| CEP290 | Orphanet:3156 | Senior-Loken syndrome |
| CEP290 | Orphanet:564 | Meckel syndrome |
| CEP290 | Orphanet:65 | Leber congenital amaurosis |
| RPGRIP1L | Orphanet:1454 | Joubert syndrome with hepatic defect |
Cohort genes → proteins
27 cohort genes, 25 distinct canonical proteins.
Evidence partition
| Subset | Genes |
|---|---|
| multi_evidence | 27 |
Cohort genes (full)
| Symbol | HGNC | Ensembl | UniProt | Name | Evidence |
|---|---|---|---|---|---|
| TMEM237 | HGNC:14432 | ENSG00000155755 | Q96Q45 | Transmembrane protein 237 | clinvar |
| PMPCA | HGNC:18667 | ENSG00000165688 | Q10713 | Mitochondrial-processing peptidase subunit alpha | clinvar |
| KIF14 | HGNC:19181 | ENSG00000118193 | Q15058 | Kinesin-like protein KIF14 | clinvar |
| KIAA0586 | HGNC:19960 | ENSG00000100578 | Q9BVV6 | Protein TALPID3 | clinvar |
| INPP5E | HGNC:21474 | ENSG00000148384 | Q9NRR6 | Phosphatidylinositol polyphosphate 5-phosphatase type IV | clinvar |
| AHI1 | HGNC:21575 | ENSG00000135541 | Q8N157 | Jouberin | clinvar |
| B9D1 | HGNC:24123 | ENSG00000108641 | Q9UPM9 | B9 domain-containing protein 1 | clinvar |
| NPHP3-AS1 | HGNC:24129 | ENSG00000248724 | NPHP3 antisense RNA 1 | clinvar | |
| TCTN3 | HGNC:24519 | ENSG00000119977 | Q6NUS6 | Tectonic-3 | clinvar |
| CEP104 | HGNC:24866 | ENSG00000116198 | O60308 | Centrosomal protein of 104 kDa | clinvar |
| TMEM216 | HGNC:25018 | ENSG00000187049 | Q9P0N5 | Transmembrane protein 216 | clinvar |
| ARL13B | HGNC:25419 | ENSG00000169379 | Q3SXY8 | ADP-ribosylation factor-like protein 13B | clinvar |
| TCTN2 | HGNC:25774 | ENSG00000168778 | Q96GX1 | Tectonic-2 | clinvar |
| CPLANE1 | HGNC:25801 | ENSG00000197603 | Q9H799 | Ciliogenesis and planar polarity effector 1 | clinvar |
| TCTN1 | HGNC:26113 | ENSG00000204852 | Q2MV58 | Tectonic-1 | clinvar |
| TMEM138 | HGNC:26944 | ENSG00000149483 | Q9NPI0 | Transmembrane protein 138 | clinvar |
| TMEM67 | HGNC:28396 | ENSG00000164953 | Q5HYA8 | Meckelin | clinvar |
| B9D2 | HGNC:28636 | ENSG00000123810 | Q9BPU9 | B9 domain-containing protein 2 | clinvar |
| CEP290 | HGNC:29021 | ENSG00000198707 | O15078 | Centrosomal protein of 290 kDa | clinvar |
| RPGRIP1L | HGNC:29168 | ENSG00000103494 | Q68CZ1 | Protein fantom | clinvar |
| CC2D2A | HGNC:29253 | ENSG00000048342 | Q9P2K1 | Coiled-coil and C2 domain-containing protein 2A | clinvar |
| LRRCC1 | HGNC:29373 | ENSG00000133739 | Q9C099 | Leucine-rich repeat and coiled-coil domain-containing protein 1 | clinvar |
| TMEM231 | HGNC:37234 | ENSG00000205084 | Q9H6L2 | Transmembrane protein 231 | clinvar |
| NPHP3-ACAD11 | HGNC:48351 | ENSG00000274810 | NPHP3-ACAD11 readthrough (NMD candidate) | clinvar | |
| MKS1 | HGNC:7121 | ENSG00000011143 | Q9NXB0 | Tectonic-like complex member MKS1 | clinvar |
| NPHP1 | HGNC:7905 | ENSG00000144061 | O15259 | Nephrocystin-1 | clinvar |
| NPHP3 | HGNC:7907 | ENSG00000113971 | Q7Z494 | Nephrocystin-3 | clinvar |
Cohort function summary
Lead sentence per gene, UniProt-curated.
| Symbol | Protein name | Function (lead sentence) |
|---|---|---|
| TMEM237 | Transmembrane protein 237 | Component of the transition zone in primary cilia. |
| PMPCA | Mitochondrial-processing peptidase subunit alpha | Substrate recognition and binding subunit of the essential mitochondrial processing protease (MPP), which cleaves the mitochondrial sequence off newly imported precursors proteins. |
| KIF14 | Kinesin-like protein KIF14 | Microtubule motor protein that binds to microtubules with high affinity through each tubulin heterodimer and has an ATPase activity. |
| KIAA0586 | Protein TALPID3 | Required for ciliogenesis and sonic hedgehog/SHH signaling. |
| INPP5E | Phosphatidylinositol polyphosphate 5-phosphatase type IV | Phosphatidylinositol (PtdIns) phosphatase that specifically hydrolyzes the 5-phosphate of phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P3), phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) and phosphatidylinositol 3,5-bispho… |
| AHI1 | Jouberin | Involved in vesicle trafficking and required for ciliogenesis, formation of primary non-motile cilium, and recruitment of RAB8A to the basal body of primary cilium. |
| B9D1 | B9 domain-containing protein 1 | Component of the tectonic-like complex, a complex localized at the transition zone of primary cilia and acting as a barrier that prevents diffusion of transmembrane proteins between the cilia and plasma membranes. |
| TCTN3 | Tectonic-3 | Part of the tectonic-like complex which is required for tissue-specific ciliogenesis and may regulate ciliary membrane composition. |
| CEP104 | Centrosomal protein of 104 kDa | Required for ciliogenesis and for structural integrity at the ciliary tip. |
| TMEM216 | Transmembrane protein 216 | Essential for primary ciliogenesis and embryonic development, facilitating the activation of Hedgehog (Hh) signaling pathway. |
| ARL13B | ADP-ribosylation factor-like protein 13B | Cilium-specific protein required to control the microtubule-based, ciliary axoneme structure. |
| TCTN2 | Tectonic-2 | Component of the tectonic-like complex, a complex localized at the transition zone of primary cilia and acting as a barrier that prevents diffusion of transmembrane proteins between the cilia and plasma membranes. |
| CPLANE1 | Ciliogenesis and planar polarity effector 1 | Involved in ciliogenesis. |
| TCTN1 | Tectonic-1 | Component of the tectonic-like complex, a complex localized at the transition zone of primary cilia and acting as a barrier that prevents diffusion of transmembrane proteins between the cilia and plasma membranes. |
| TMEM138 | Transmembrane protein 138 | Required for ciliogenesis. |
| TMEM67 | Meckelin | Required for ciliary structure and function. |
| B9D2 | B9 domain-containing protein 2 | Component of the tectonic-like complex, a complex localized at the transition zone of primary cilia and acting as a barrier that prevents diffusion of transmembrane proteins between the cilia and plasma membranes. |
| CEP290 | Centrosomal protein of 290 kDa | Involved in early and late steps in cilia formation. |
| RPGRIP1L | Protein fantom | Negatively regulates signaling through the G-protein coupled thromboxane A2 receptor (TBXA2R). |
| CC2D2A | Coiled-coil and C2 domain-containing protein 2A | Component of the tectonic-like complex, a complex localized at the transition zone of primary cilia and acting as a barrier that prevents diffusion of transmembrane proteins between the cilia and plasma membranes. |
| LRRCC1 | Leucine-rich repeat and coiled-coil domain-containing protein 1 | Required for the organization of the mitotic spindle. |
| TMEM231 | Transmembrane protein 231 | Transmembrane component of the tectonic-like complex, a complex localized at the transition zone of primary cilia and acting as a barrier that prevents diffusion of transmembrane proteins between the cilia and plasma membranes. |
| MKS1 | Tectonic-like complex member MKS1 | Component of the tectonic-like complex, a complex localized at the transition zone of primary cilia and acting as a barrier that prevents diffusion of transmembrane proteins between the cilia and plasma membranes. |
| NPHP1 | Nephrocystin-1 | Together with BCAR1 it may play a role in the control of epithelial cell polarity. |
| NPHP3 | Nephrocystin-3 | Required for normal ciliary development and function. |
Protein-family classification
Druggable: 3 · Difficult: 4 · Unknown: 20 · Druggable fraction: 0.11
Family distribution
Cohort families vs a genome-wide background (hypergeometric, BH-FDR; fold = observed/expected). Counts kept; sorted by enrichment, so the catch-all Other/Unknown bucket no longer leads.
| Family | Genes | Fold | FDR |
|---|---|---|---|
| Other/Unknown | 20 | 1.3× | 0.203 |
| Protease | 2 | 2.7× | 0.339 |
| Scaffold/PPI | 3 | 1.9× | 0.339 |
| Enzyme (other) | 1 | 0.4× | 0.969 |
| Transcription factor | 1 | 0.3× | 0.969 |
Per-gene assignment
| Symbol | Family | Druggable? | EC | InterPro (top 3) |
|---|---|---|---|---|
| TMEM237 | Other/Unknown | no | TMEM237 | |
| PMPCA | Protease | yes | 3.4.24.64 | Pept_M16_Zn_BS, Peptidase_M16_C, Metalloenz_LuxS/M16 |
| KIF14 | Other/Unknown | no | FHA_dom, Kinesin_motor_dom, SMAD_FHA_dom_sf | |
| KIAA0586 | Other/Unknown | no | TALPID3 | |
| INPP5E | Enzyme (other) | yes | 3.1.3.36 | IPPc, Endo/exonu/phosph_ase_sf, INPP5E |
| AHI1 | Scaffold/PPI | no | SH3_domain, WD40_rpt, WD40/YVTN_repeat-like_dom_sf | |
| B9D1 | Other/Unknown | no | C2_B9-type_dom | |
| NPHP3-AS1 | Other/Unknown | no | ||
| TCTN3 | Other/Unknown | no | TCTN1-3_dom, TCTN1-3, TCTN1-3_N | |
| CEP104 | Transcription factor | no | Galactose-bd-like_sf, ARM-like, ARM-type_fold | |
| TMEM216 | Other/Unknown | no | Uncharacterised_TM-17 | |
| ARL13B | Other/Unknown | no | Small_GTP-bd, Small_GTPase_ARF/SAR, P-loop_NTPase | |
| TCTN2 | Other/Unknown | no | TCTN1-3_dom, TCTN1-3, TCTN1-3_N | |
| CPLANE1 | Scaffold/PPI | no | CPLANE1, WD40_repeat_dom_sf | |
| TCTN1 | Other/Unknown | no | TCTN1-3_dom, TCTN1-3, TCTN1-3_N | |
| TMEM138 | Other/Unknown | no | TM_138 | |
| TMEM67 | Other/Unknown | no | Growth_fac_rcpt_cys_sf, Meckelin | |
| B9D2 | Other/Unknown | no | C2_B9-type_dom | |
| CEP290 | Other/Unknown | no | Cep290, Cep209_CC5 | |
| RPGRIP1L | Other/Unknown | no | C2_dom, C2-C2_1, RPGRIP1_fam | |
| CC2D2A | Protease | yes | C2_dom, CC2D2AN-C2, C2_domain_sf | |
| LRRCC1 | Other/Unknown | no | Leu-rich_rpt, Leu-rich_rpt_4, LRR_dom_sf | |
| TMEM231 | Other/Unknown | no | TMEM231 | |
| NPHP3-ACAD11 | Other/Unknown | no | ||
| MKS1 | Other/Unknown | no | C2_B9-type_dom | |
| NPHP1 | Scaffold/PPI | no | SH3_domain, NPHP1_SH3, SH3-like_dom_sf | |
| NPHP3 | Other/Unknown | no | TPR-like_helical_dom_sf, TPR_rpt, P-loop_NTPase |
Expression context
Cohort genes with no expression data: 0.
25 cohort genes are a single-cell marker in ≥1 SCXA experiment.
Breadth distribution (Bgee present_calls)
| Bucket | Genes |
|---|---|
| narrow (1-5 tissues) | 0 |
| moderate (6-20) | 0 |
| broad (>20) | 27 |
| unknown | 0 |
Top tissues across cohort
| Tissue | Cohort genes |
|---|---|
| right uterine tube | 9 |
| calcaneal tendon | 7 |
| male germ line stem cell (sensu Vertebrata) in testis | 6 |
| secondary oocyte | 5 |
| bronchial epithelial cell | 5 |
| olfactory segment of nasal mucosa | 4 |
| ventricular zone | 3 |
| adenohypophysis | 3 |
| buccal mucosa cell | 3 |
| adrenal tissue | 2 |
| left testis | 2 |
| pituitary gland | 2 |
| sural nerve | 2 |
| primordial germ cell in gonad | 2 |
| bronchus | 2 |
| left ovary | 2 |
| apex of heart | 1 |
| right lobe of liver | 1 |
| endometrium epithelium | 1 |
| trabecular bone tissue | 1 |
Per-gene tissue summary (top 30)
| Symbol | Bgee breadth | FANTOM5 breadth | SCXA | Top tissues |
|---|---|---|---|---|
| TMEM237 | 250 | ubiquitous | marker | calcaneal tendon, adrenal tissue, ventricular zone |
| PMPCA | 276 | ubiquitous | marker | right lobe of liver, adrenal tissue, apex of heart |
| KIF14 | 144 | ubiquitous | marker | secondary oocyte, endometrium epithelium, trabecular bone tissue |
| KIAA0586 | 247 | ubiquitous | marker | male germ line stem cell (sensu Vertebrata) in testis, right testis, left testis |
| INPP5E | 279 | ubiquitous | yes | right uterine tube, secondary oocyte, oocyte |
| AHI1 | 276 | ubiquitous | marker | pituitary gland, calcaneal tendon, right hemisphere of cerebellum |
| B9D1 | 224 | ubiquitous | marker | right uterine tube, adenohypophysis, left testis |
| NPHP3-AS1 | 59 | marker | sural nerve, secondary oocyte, male germ line stem cell (sensu Vertebrata) in testis | |
| TCTN3 | 267 | ubiquitous | marker | corpus epididymis, decidua, stromal cell of endometrium |
| CEP104 | 284 | ubiquitous | marker | secondary oocyte, buccal mucosa cell, sperm |
| TMEM216 | 239 | ubiquitous | marker | primordial germ cell in gonad, adenohypophysis, pituitary gland |
| ARL13B | 237 | ubiquitous | marker | secondary oocyte, calcaneal tendon, bronchial epithelial cell |
| TCTN2 | 218 | ubiquitous | marker | buccal mucosa cell, tendon of biceps brachii, olfactory bulb |
| CPLANE1 | 195 | ubiquitous | marker | sural nerve, calcaneal tendon, male germ line stem cell (sensu Vertebrata) in testis |
| TCTN1 | 230 | ubiquitous | marker | right uterine tube, adenohypophysis, olfactory segment of nasal mucosa |
| TMEM138 | 245 | ubiquitous | marker | right adrenal gland, right adrenal gland cortex, left adrenal gland |
| TMEM67 | 203 | ubiquitous | marker | buccal mucosa cell, right uterine tube, calcaneal tendon |
| B9D2 | 138 | ubiquitous | marker | right uterine tube, blood, olfactory segment of nasal mucosa |
| CEP290 | 278 | ubiquitous | marker | right uterine tube, male germ line stem cell (sensu Vertebrata) in testis, ventricular zone |
| RPGRIP1L | 207 | ubiquitous | marker | bronchial epithelial cell, primordial germ cell in gonad, male germ line stem cell (sensu Vertebrata) in testis |
| CC2D2A | 247 | ubiquitous | marker | right uterine tube, bronchial epithelial cell, bronchus |
| LRRCC1 | 189 | ubiquitous | marker | calcaneal tendon, ventricular zone, C1 segment of cervical spinal cord |
| TMEM231 | 257 | ubiquitous | marker | bronchial epithelial cell, epithelium of bronchus, bronchus |
| NPHP3-ACAD11 | 133 | tissue_specific | yes | male germ line stem cell (sensu Vertebrata) in testis, calcaneal tendon, endometrium |
| MKS1 | 182 | ubiquitous | marker | right uterine tube, olfactory segment of nasal mucosa, left ovary |
| NPHP1 | 193 | ubiquitous | marker | right uterine tube, bronchial epithelial cell, olfactory segment of nasal mucosa |
| NPHP3 | 254 | ubiquitous | marker | superficial temporal artery, layer of synovial tissue, left ovary |
Protein interactions among cohort
Intra-cohort edges: 144.
Hub genes (top 10 by interactor count)
| Symbol | Interactor count |
|---|---|
| KIF14 | 6,868 |
| PMPCA | 3,679 |
| CEP290 | 2,778 |
| ARL13B | 2,558 |
| NPHP1 | 2,302 |
| NPHP3 | 2,275 |
| TMEM237 | 2,169 |
| RPGRIP1L | 2,027 |
| AHI1 | 1,681 |
| KIAA0586 | 1,405 |
Intra-cohort edges
| A | B | Sources |
|---|---|---|
| AHI1 | ARL13B | string_interaction |
| AHI1 | B9D1 | string_interaction |
| AHI1 | B9D2 | string_interaction |
| AHI1 | CC2D2A | biogrid_interaction, intact, string_interaction |
| AHI1 | CEP290 | string_interaction |
| AHI1 | CPLANE1 | string_interaction |
| AHI1 | NPHP1 | intact, string_interaction |
| AHI1 | RPGRIP1L | string_interaction |
| AHI1 | TCTN1 | string_interaction |
| AHI1 | TCTN2 | string_interaction |
| AHI1 | TCTN3 | string_interaction |
| AHI1 | TMEM138 | string_interaction |
| AHI1 | TMEM216 | string_interaction |
| AHI1 | TMEM231 | string_interaction |
| AHI1 | TMEM67 | string_interaction |
| ARL13B | CC2D2A | string_interaction |
| ARL13B | CEP290 | string_interaction |
| ARL13B | INPP5E | string_interaction |
| ARL13B | NPHP1 | string_interaction |
| ARL13B | RPGRIP1L | string_interaction |
| ARL13B | TMEM216 | string_interaction |
| ARL13B | TMEM67 | string_interaction |
| B9D1 | B9D2 | biogrid_interaction, intact, string_interaction |
| B9D1 | CC2D2A | biogrid_interaction, intact, string_interaction |
| B9D1 | CEP290 | string_interaction |
| B9D1 | MKS1 | biogrid_interaction, intact, string_interaction |
| B9D1 | NPHP1 | string_interaction |
| B9D1 | RPGRIP1L | string_interaction |
| B9D1 | TCTN1 | intact, string_interaction |
| B9D1 | TCTN2 | intact, string_interaction |
| B9D1 | TCTN3 | string_interaction |
| B9D1 | TMEM138 | string_interaction |
| B9D1 | TMEM216 | string_interaction |
| B9D1 | TMEM231 | biogrid_interaction, intact, string_interaction |
| B9D1 | TMEM237 | string_interaction |
| B9D1 | TMEM67 | string_interaction |
| B9D2 | CC2D2A | biogrid_interaction, intact, string_interaction |
| B9D2 | CEP290 | string_interaction |
| B9D2 | MKS1 | biogrid_interaction, intact |
| B9D2 | NPHP1 | string_interaction |
| B9D2 | RPGRIP1L | string_interaction |
| B9D2 | TCTN1 | intact, string_interaction |
| B9D2 | TCTN2 | string_interaction |
| B9D2 | TCTN3 | intact, string_interaction |
| B9D2 | TMEM216 | string_interaction |
| B9D2 | TMEM231 | biogrid_interaction, intact, string_interaction |
| B9D2 | TMEM237 | string_interaction |
| B9D2 | TMEM67 | string_interaction |
| CC2D2A | CEP290 | string_interaction |
| CC2D2A | CPLANE1 | string_interaction |
Structural data
PDB: 7 · AlphaFold-only: 18 · No structure: 2
Cohort genes with PDB structures (top 30)
| Symbol | UniProt | PDB entries |
|---|---|---|
| CEP104 | O60308 | 2 |
| NPHP1 | O15259 | 2 |
| INPP5E | Q9NRR6 | 1 |
| AHI1 | Q8N157 | 1 |
| TMEM67 | Q5HYA8 | 1 |
| RPGRIP1L | Q68CZ1 | 1 |
| NPHP3 | Q7Z494 | 1 |
AlphaFold-only cohort genes (top 30 by pLDDT)
| Symbol | UniProt | pLDDT |
|---|---|---|
| B9D2 | Q9BPU9 | 89.79 |
| TMEM216 | Q9P0N5 | 89.18 |
| TMEM231 | Q9H6L2 | 88.65 |
| PMPCA | Q10713 | 88.46 |
| TMEM138 | Q9NPI0 | 86.42 |
| B9D1 | Q9UPM9 | 83.05 |
| TCTN1 | Q2MV58 | 78.10 |
| TCTN2 | Q96GX1 | 74.71 |
| LRRCC1 | Q9C099 | 74.43 |
| MKS1 | Q9NXB0 | 74.05 |
| ARL13B | Q3SXY8 | 72.92 |
| TCTN3 | Q6NUS6 | 71.49 |
| CC2D2A | Q9P2K1 | 69.46 |
| KIF14 | Q15058 | 65.68 |
| TMEM237 | Q96Q45 | 63.79 |
| CEP290 | O15078 | 60.90 |
| KIAA0586 | Q9BVV6 | 47.61 |
| CPLANE1 | Q9H799 |
Function
Pathway analysis
Distinct Reactome pathways touched by cohort: 62. Enrichment computed across 27 evidence-associated genes (18 with Reactome annotation).
Pathways by enrichment
Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 18 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.
| Pathway | Cohort genes | Fold | FDR | Sample cohort genes |
|---|---|---|---|---|
| Anchoring of the basal body to the plasma membrane | 13 | 81.7× | 5e-22 | AHI1, B9D1, TCTN3, TMEM216, TCTN2, TCTN1, TMEM67, B9D2 (+5 more) |
| Cilium Assembly | 12 | 72.5× | 1e-19 | INPP5E, AHI1, B9D1, TCTN3, ARL13B, TCTN2, TCTN1, TMEM67 (+4 more) |
| Organelle biogenesis and maintenance | 12 | 44.0× | 4e-17 | INPP5E, AHI1, B9D1, TCTN3, ARL13B, TCTN2, TCTN1, TMEM67 (+4 more) |
| ARL13B-mediated ciliary trafficking of INPP5E | 2 | 423.0× | 1e-04 | INPP5E, ARL13B |
| Cargo trafficking to the periciliary membrane | 2 | 27.6× | 0.029 | INPP5E, ARL13B |
| Hedgehog ‘off’ state | 2 | 19.8× | 0.046 | RPGRIP1L, MKS1 |
| Trafficking of myristoylated proteins to the cilium | 1 | 126.9× | 0.070 | NPHP3 |
| Signaling by Rho GTPases | 3 | 5.7× | 0.106 | KIF14, ARL13B, B9D2 |
| Signaling by Rho GTPases, Miro GTPases and RHOBTB3 | 3 | 5.6× | 0.106 | KIF14, ARL13B, B9D2 |
| Synthesis of PIPs at the Golgi membrane | 1 | 35.2× | 0.123 | INPP5E |
| Processing of SMDT1 | 1 | 35.2× | 0.123 | PMPCA |
| RHO GTPases activate CIT | 1 | 33.4× | 0.123 | KIF14 |
| Mitochondrial calcium ion transport | 1 | 30.2× | 0.123 | PMPCA |
| Chaperone Mediated Autophagy | 1 | 27.6× | 0.123 | ARL13B |
| Mitotic Prometaphase | 2 | 7.7× | 0.123 | B9D2, CEP290 |
| RHO GTPase Effectors | 2 | 7.5× | 0.123 | KIF14, B9D2 |
| M Phase | 2 | 7.3× | 0.123 | B9D2, CEP290 |
| RHO GTPase cycle | 2 | 6.7× | 0.123 | KIF14, ARL13B |
| PI Metabolism | 1 | 19.8× | 0.159 | INPP5E |
| Late endosomal microautophagy | 1 | 18.1× | 0.159 | ARL13B |
| Cell Cycle, Mitotic | 2 | 5.3× | 0.159 | B9D2, CEP290 |
| Selective autophagy | 1 | 15.5× | 0.167 | ARL13B |
| RND1 GTPase cycle | 1 | 14.8× | 0.167 | KIF14 |
| RND2 GTPase cycle | 1 | 14.4× | 0.167 | KIF14 |
| Centrosome maturation | 1 | 14.1× | 0.167 | CEP290 |
| Aggrephagy | 1 | 13.8× | 0.167 | ARL13B |
| Phospholipid metabolism | 1 | 11.1× | 0.173 | INPP5E |
| RHOJ GTPase cycle | 1 | 11.1× | 0.173 | ARL13B |
| Amplification of signal from the kinetochores | 1 | 10.9× | 0.173 | B9D2 |
| Protein localization | 1 | 10.6× | 0.173 | PMPCA |
GO biological processes by enrichment
Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 24 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.
| GO term | Cohort genes | Fold | FDR | Sample cohort genes |
|---|---|---|---|---|
| cilium assembly | 19 | 58.3× | 9e-30 | TMEM237, KIAA0586, INPP5E, AHI1, B9D1, TCTN3, TMEM216, ARL13B (+11 more) |
| non-motile cilium assembly | 7 | 84.7× | 9e-11 | TMEM216, ARL13B, CEP290, RPGRIP1L, CC2D2A, MKS1, NPHP3 |
| smoothened signaling pathway | 7 | 52.9× | 2e-09 | KIAA0586, B9D1, TCTN3, ARL13B, TCTN2, CC2D2A, TMEM231 |
| protein localization to ciliary transition zone | 3 | 300.9× | 3e-06 | TCTN2, TCTN1, CC2D2A |
| camera-type eye development | 4 | 59.8× | 2e-05 | B9D1, CEP290, CC2D2A, TMEM231 |
| determination of left/right symmetry | 4 | 42.6× | 5e-05 | RPGRIP1L, CC2D2A, MKS1, NPHP3 |
| regulation of smoothened signaling pathway | 3 | 78.0× | 1e-04 | TCTN1, RPGRIP1L, MKS1 |
| motile cilium assembly | 3 | 72.6× | 2e-04 | AHI1, CC2D2A, MKS1 |
| regulation of Wnt signaling pathway, planar cell polarity pathway | 2 | 280.9× | 3e-04 | MKS1, NPHP3 |
| kidney development | 4 | 23.4× | 3e-04 | CEP290, RPGRIP1L, CC2D2A, NPHP3 |
| neural tube patterning | 2 | 234.1× | 4e-04 | ARL13B, RPGRIP1L |
| regulation of establishment of protein localization | 2 | 200.6× | 5e-04 | KIAA0586, CEP290 |
| embryonic digit morphogenesis | 3 | 37.6× | 7e-04 | B9D1, TMEM231, MKS1 |
| neuroepithelial cell differentiation | 2 | 127.7× | 0.001 | B9D1, TMEM231 |
| vasculature development | 2 | 93.6× | 0.002 | B9D1, TMEM231 |
| in utero embryonic development | 4 | 12.0× | 0.003 | B9D1, TCTN1, RPGRIP1L, TMEM231 |
| dorsal/ventral neural tube patterning | 2 | 66.9× | 0.003 | TCTN1, MKS1 |
| embryonic brain development | 2 | 66.9× | 0.003 | CC2D2A, MKS1 |
| olfactory bulb development | 2 | 63.8× | 0.003 | KIF14, RPGRIP1L |
| smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation | 1 | 702.2× | 0.008 | MKS1 |
| cerebellar granular layer structural organization | 1 | 702.2× | 0.008 | KIF14 |
| interneuron migration from the subpallium to the cortex | 1 | 702.2× | 0.008 | ARL13B |
| central nervous system interneuron axonogenesis | 1 | 702.2× | 0.008 | TCTN1 |
| determination of intestine left/right asymmetry | 1 | 702.2× | 0.008 | NPHP3 |
| determination of stomach left/right asymmetry | 1 | 702.2× | 0.008 | NPHP3 |
| regulation of cell maturation | 1 | 702.2× | 0.008 | KIF14 |
| establishment or maintenance of cell polarity | 2 | 33.4× | 0.009 | RPGRIP1L, NPHP3 |
| photoreceptor cell maintenance | 2 | 29.9× | 0.010 | TMEM216, NPHP3 |
| cerebellar Purkinje cell layer structural organization | 1 | 351.1× | 0.013 | KIF14 |
| convergent extension involved in gastrulation | 1 | 351.1× | 0.013 | NPHP3 |
Therapeutics
Drug target analysis
Approved (phase 4): 0 · Phase ≥3: 0 · Phased (≥1): 0 · Undrugged: 27
Druggability breadth: 2 of 27 evidence-associated genes (7%) have a ChEMBL target (buckets above are over the deeply-mined display cohort).
Top cohort targets by molecule count
| Symbol | Molecules | Max phase |
|---|---|---|
| TMEM237 | 0 | 0 |
| PMPCA | 0 | 0 |
| KIF14 | 0 | 0 |
| KIAA0586 | 0 | 0 |
| INPP5E | 0 | 0 |
| AHI1 | 0 | 0 |
| B9D1 | 0 | 0 |
| NPHP3-AS1 | 0 | 0 |
| TCTN3 | 0 | 0 |
| CEP104 | 0 | 0 |
Bioactivity and enzyme data
Enzyme cohort genes (≥1 EC): 2.
Cohort genes with ChEMBL bioactivity (full, sorted by assay count)
| Symbol | Assays | Type breakdown |
|---|---|---|
| PMPCA | 1 | Binding:1 |
| KIF14 | 1 | Binding:1 |
Cohort enzymes (BRENDA EC)
| Symbol | EC numbers | Names |
|---|---|---|
| PMPCA | 3.4.24.64 | mitochondrial processing peptidase |
| INPP5E | 3.1.3.36 | phosphoinositide 5-phosphatase |
Pharmacogenomics
Cohort genes with a PharmGKB record: 26; with CPIC/DPWG dosing guidelines: 0.
No cohort gene has a CPIC/DPWG genotype-guided dosing guideline (PharmGKB).
Chemical tractability of cohort targets
0 approved/phased compounds have measured bioactivity against a cohort gene (and aren’t yet in disease-level trials). This is a research / tractability signal, NOT a therapeutic recommendation — a bioactivity row often reflects off-target or screening binding (e.g. promiscuous kinase inhibitors against a cohort kinase), implying no disease mechanism.
Druggability pyramid
Cohort genes binned by druggability tier (high → low):
| Tier | Definition | Genes | Symbols |
|---|---|---|---|
| A | Approved (phase 4 drug) | 0 | |
| B | Phased (≥1) drug, not yet approved | 0 | |
| C | Druggable family + PDB, no drug | 1 | INPP5E |
| D | Druggable family + AlphaFold only, no drug | 2 | PMPCA, CC2D2A |
| E | Difficult family or no structure, no drug | 24 | TMEM237, KIF14, KIAA0586, AHI1, B9D1, NPHP3-AS1, TCTN3, CEP104, TMEM216, ARL13B (+14 more) |
Undrugged target profiles
27 cohort genes are undrugged. Ranked by ‘starting-point quality’ (assay depth + drugged-partner adjacency).
| Symbol | ChEMBL assays | Drugged partners (top 3) |
|---|---|---|
| TMEM237 | 0 | — |
| PMPCA | 1 | — |
| KIF14 | 1 | — |
| KIAA0586 | 0 | — |
| INPP5E | 0 | — |
| AHI1 | 0 | — |
| B9D1 | 0 | — |
| NPHP3-AS1 | 0 | — |
| TCTN3 | 0 | — |
| CEP104 | 0 | — |
| TMEM216 | 0 | — |
| ARL13B | 0 | — |
| TCTN2 | 0 | — |
| CPLANE1 | 0 | — |
| TCTN1 | 0 | — |
| TMEM138 | 0 | — |
| TMEM67 | 0 | — |
| B9D2 | 0 | — |
| CEP290 | 0 | — |
| RPGRIP1L | 0 | — |
| CC2D2A | 0 | — |
| LRRCC1 | 0 | — |
| TMEM231 | 0 | — |
| NPHP3-ACAD11 | 0 | — |
| MKS1 | 0 | — |
| NPHP1 | 0 | — |
| NPHP3 | 0 | — |
Clinical trials & evidence
Clinical trials
Clinical trials: 0.